- Investing Ideas
- /
- Hong Kong Undervalued Stocks Based On Cash Flows
Hong Kong Undervalued Stocks Based On Cash Flows
Results
32
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
32 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | HK$68.05 | -2.4% | -22.4% | HK$192.5b | HK$108.61 | PE17.4x | E12.7% | 3.4% | Consumer Durables | ||
1501 | HK$28.25 | 1.6% | 4.6% | HK$4.9b | HK$35.04 | PE30.1x | E25.4% | 1.0% | Healthcare | ||
2111 | HK$2.20 | -0.5% | 117.8% | HK$2.4b | HK$1.93 | PE6.6x | E24.3% | 7.6% | Consumer Durables | ||
1119 | HK$2.20 | -9.5% | -37.3% | HK$3.7b | HK$4.84 | PS1.8x | E104.1% | n/a | Media | ||
596 | HK$3.05 | 3.0% | 11.3% | HK$3.5b | HK$5.00 | PE16x | E38.0% | 1.0% | Software | ||
1801 | HK$39.25 | 0.9% | 19.7% | HK$63.4b | HK$55.92 | PS9.5x | E50.5% | n/a | Pharmaceuticals & Biotech | ||
2160 | HK$0.75 | -1.3% | -64.5% | HK$1.8b | HK$2.19 | PS5x | E98.6% | n/a | Healthcare | ||
2013 | HK$1.19 | 0% | -71.2% | HK$3.7b | HK$2.32 | PS1.5x | E109.9% | n/a | Software | ||
285 | HK$29.30 | -4.7% | -3.3% | HK$68.3b | HK$42.96 | PE15.1x | E22.3% | 2.0% | Tech | ||
1382 | HK$1.69 | 0.6% | -10.6% | HK$2.4b | HK$3.32 | PE14.1x | E37.7% | 7.1% | Consumer Durables | ||
3998 | HK$3.90 | 4.3% | 10.5% | HK$43.3b | HK$5.58 | PE12.9x | E12.8% | 6.4% | Consumer Durables | ||
3393 | HK$6.30 | 3.4% | 109.3% | HK$6.4b | HK$6.90 | PE11.1x | E25.8% | 4.4% | Tech | ||
973 | HK$33.85 | 0% | 37.3% | HK$50.0b | HK$33.58 | PE63x | E25.6% | 0% | Household | ||
1911 | HK$7.27 | 0% | -26.2% | HK$4.1b | HK$12.69 | PS2.6x | E97.8% | 5.7% | Diversified Financials | ||
1548 | HK$11.86 | -5.0% | -41.0% | HK$25.9b | HK$24.14 | PS3.8x | E97.9% | 0% | Pharmaceuticals & Biotech | ||
2325 | HK$8.30 | -6.4% | -31.7% | HK$5.2b | HK$13.99 | PS5.2x | E97.8% | 0.2% | Healthcare | ||
799 | HK$2.72 | 0% | -32.0% | HK$3.1b | HK$4.22 | PE42.2x | E51.2% | n/a | Media | ||
6616 | HK$3.86 | -4.2% | -14.6% | HK$4.7b | HK$5.83 | PE24.3x | E41.8% | 0% | Materials | ||
9886 | HK$1.07 | 11.5% | -62.3% | HK$1.4b | HK$1.56 | PB0.7x | E84.4% | n/a | Consumer Retailing | ||
2400 | HK$22.55 | 13.7% | 22.2% | HK$11.1b | HK$20.17 | PS2.9x | E56.8% | n/a | Media | ||
1952 | HK$19.34 | 3.0% | -2.3% | HK$6.2b | HK$26.07 | PS45.5x | E76.3% | n/a | Pharmaceuticals & Biotech | ||
9923 | HK$11.00 | -0.4% | -40.3% | HK$4.8b | HK$15.72 | PE374.4x | E51.5% | n/a | Diversified Financials | ||
1516 | HK$1.69 | -1.2% | -35.0% | HK$5.2b | HK$1.87 | PB0.8x | E60.4% | 9.2% | Real Estate Management and Development | ||
1821 | HK$11.50 | -1.4% | -9.9% | HK$49.4b | HK$15.43 | PE30.5x | E26.3% | 2.2% | Real Estate Management and Development |